480
Participants
Start Date
June 4, 2020
Primary Completion Date
May 31, 2030
Study Completion Date
May 31, 2030
Data collection for parameters of organ damage (cardiac and renal blood markers)
Blood results will be taken out of next routine venipuncture. Routinely collected standard parameters are a blood count, chemistry panel including renal parameters and electrolytes, lipid profile and a HbA1c as well as albumin/creatinine and protein/creatinine ratio in urine.
Data collection for blood pressure (BP)
Clinic blood pressure and 24hour BP Measurements
Home-based blood pressure management (substudy)
Subjects participating in home-based blood pressure management via telemonitoring will receive a free HekaHealth application (App) for the structured assessment of HBPM.
Biomarker Profiles (substudy)
Substudy where possible cardiac, renal and pregnancy related biomarkers will be additionally analyzed. The following biomarkers will be analyzed: N terminal (NT)-proBNP, Troponin, elevated mid-regional pro-atrial natriuretic peptide (ANP), elevated mid-regional pro adrenomedullin (ADM), soluble fms-like tyrosine kinase (sFlt-1), and placenta growth factor (PlGF).
Data collection on patient reported outcomes
Data collection on patient reported outcomes (Questionnaire EQ-5D, Questionnaire for App based monitoring )
RECRUITING
Medical Outpatient Department and Hypertension Clinic, University Hospital Basel, Basel
University Hospital, Basel, Switzerland
OTHER